A multifunctional hydrogel co-loaded with osteogenic peptide P24 and antioxidant nanozymes accelerated bone regeneration by reducing inflammation, promoting blood vessel growth, and enhancing bone formation in animal models.
Triple-action scaffoldCombines anti-inflammatory, pro-angiogenic, and osteogenic functions in one hydrogel for bone repair
What the researchers found
The triple-component hydrogel (RGD@DEXMA/DOPA-P24/Mn3O4) synergistically reduced ROS-driven inflammation, promoted M1-to-M2 macrophage polarization and angiogenesis, and enhanced osteogenic differentiation of bone marrow stem cells, accelerating bone defect regeneration in vivo.
Why it matters
Bone defects often heal poorly because excessive inflammation disrupts the cooperation between immune cells and bone-forming cells. This hydrogel addresses both problems simultaneously—calming inflammation while actively promoting bone growth through sustained peptide release—offering a potential advance in regenerative orthopedic materials.
The numbers in context
Mn3O4 nanozymes scavenged ROS and induced M1-to-M2 macrophage polarization. DOPA moiety enabled sustained release of P24 peptide. RGD sequence promoted BMSC adhesion and proliferation. Tested in vivo in bone defect models.
How the study worked
In vitro cell culture studies with BMSCs and macrophages plus in vivo bone defect models in animals, evaluating ROS scavenging, macrophage polarization, angiogenesis, and bone regeneration.
Who was studied
Animal bone defect model (species not specified in abstract)
What this study cannot tell us
The study used animal models, and results may not directly translate to human bone healing. Long-term safety and degradation profiles of the nanozyme component were not extensively characterized. Specific quantitative outcomes (e.g., bone volume fractions) were not highlighted in the abstract.
How to read the evidence
Preclinical study with both in vitro mechanistic data and in vivo animal bone defect models. Promising but not yet tested in humans.
When this study was published
Published in 2025; represents current state-of-the-art in peptide-functionalized bone scaffolds.
The bigger picture
This study exemplifies a growing trend in regenerative medicine: combining bioactive peptides with immunomodulatory agents in a single scaffold to address both the inflammatory and regenerative phases of tissue repair. If translatable to humans, such multifunctional biomaterials could improve outcomes in complex fractures and large bone defects.
Questions still open
- How would this hydrogel perform in larger, clinically relevant bone defect models?
- What is the long-term fate and safety profile of Mn3O4 nanozymes in vivo?
- Could the P24 peptide component be effective without the nanozyme in less inflammatory contexts?
Common questions
What is the P24 peptide used in this study?
Why is reducing inflammation important for bone healing?
Read the original research
RGD-grafted dextran methacrylate hydrogel incorporating osteogenic peptide and Mn3O4 nanozymes for enhanced bone defect healing.
Materials today. Bio, 35, 102436
Citation
Pang, Yuxuan; Wang, Xin; Zhang, Huan; Li, Xin; Lin, Min; Cheng, Liang; Yang, Ying-Wei. (2025). RGD-grafted dextran methacrylate hydrogel incorporating osteogenic peptide and Mn3O4 nanozymes for enhanced bone defect healing.. Materials today. Bio, 35, 102436. https://doi.org/10.1016/j.mtbio.2025.102436